Insiders · ELTX

ELTX insider transactions

Elicio Therapeutics Inc. (ELTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ELTX

• 81d
  CEO, President and Director Connelly Robert was granted 73,600 shares, increasing direct ownership by 157% to 120,570 units (SEC Form 4)

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 81d
  Officer Shah Preetam was granted 24,000 shares (SEC Form 4)

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 81d
  Chief Scientific Officer Demuth Peter was granted 20,800 shares, increasing direct ownership by 2,799% to 21,543 units (SEC Form 4)

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 81d
  Officer Haqq Christopher was granted 25,400 shares, increasing direct ownership by 79% to 57,381 units (SEC Form 4)

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 136d
  Chief Scientific Officer Demuth Peter exercised 362 shares at a strike of $4.41, increasing direct ownership by 95% to 743 units (SEC Form 4)

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 326d
  SEC Form 4 filed by Director Chudnovsky Yekaterina

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 341d
  SEC Form 4 filed by Director Ashe Carol Gail

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 341d
  SEC Form 4 filed by Director Nissenson Allen

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 341d
  SEC Form 4 filed by Director Venkatesan Jay

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 341d
  SEC Form 4 filed by Director Adams Julian

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 341d
  SEC Form 4 filed by Director Wilson Karen J

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 341d
  SEC Form 4 filed by Director Ruffolo Robert R

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 341d
  SEC Form 4 filed by Director Chudnovsky Yekaterina

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 375d
  SEC Form 4 filed by Officer Shah Preetam

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 389d
  SEC Form 3 filed by new insider Shah Preetam

  3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 415d
  Director Chudnovsky Yekaterina converted options into 3,500,573 shares (SEC Form 4)

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 446d
  SEC Form 4 filed by Chief Scientific Officer Demuth Peter

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 446d
  SEC Form 4 filed by Officer Haqq Christopher

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 446d
  SEC Form 4 filed by CEO, President and Director Connelly Robert

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 479d
  Amendment: SEC Form 4 filed by Director Venkatesan Jay

  4/A - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 493d
  Chief Scientific Officer Demuth Peter exercised 381 shares at a strike of $4.41 (SEC Form 4)

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 513d
  Director Venkatesan Jay exercised 50,000 in-the-money shares at a strike of $0.01, increasing direct ownership by 39% to 179,581 units (SEC Form 4)

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 517d
  SEC Form 4 filed by Director Wilson Karen J

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 517d
  SEC Form 4 filed by Director Adams Julian

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 517d
  SEC Form 4 filed by Director Ashe Carol Gail

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 517d
  SEC Form 4 filed by Director Venkatesan Jay

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 517d
  SEC Form 4 filed by Director Ruffolo Robert R

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 517d
  SEC Form 4 filed by Director Chudnovsky Yekaterina

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 517d
  SEC Form 4 filed by Director Nissenson Allen

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 571d
  SEC Form 4 filed by CEO, President and Director Connelly Robert

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 571d
  SEC Form 4 filed by Chief Scientific Officer Demuth Peter

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 571d
  SEC Form 4 filed by Officer Haqq Christopher

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 620d
  SEC Form 4 filed by Director Chudnovsky Yekaterina

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 662d
  SEC Form 4 filed by Director Venkatesan Jay

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 663d
  SEC Form 4 filed by Director Chudnovsky Yekaterina

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
• 767d
  SEC Form 4 filed by Chudnovsky Yekaterina

  4 - Elicio Therapeutics, Inc. (0001601485) (Issuer)